<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Best Practices in Developing Proprietary Names for Human Prescription Drug Products; Guidance for Industry; Availability</h1>
    <p class="timestamp">Published: 2020-12-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled "Best Practices in Developing Proprietary Names for Human Prescription Drug Products." This document provides guidance to sponsors on the development and selection of proposed proprietary names. This guidance describes best practices to help minimize medication errors and otherwise avoid adoption of proprietary names that contribute to violations of the Federal Food, Drug, an...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2020-27058</p>
    <p><strong>Publication Date:</strong> 2020-12-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2020/12/09/2020-27058/best-practices-in-developing-proprietary-names-for-human-prescription-drug-products-guidance-for">https://www.federalregister.gov/documents/2020/12/09/2020-27058/best-practices-in-developing-proprietary-names-for-human-prescription-drug-products-guidance-for</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2020-27058</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
